FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMENT OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JANUARY 12, 2020

Results 201 through 232 of 232

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
STNN Over the counter Skye Life Ventures Ltd 2834
STRO Nasdaq Sutro Biopharma Inc 2834
SUPN Nasdaq Supernus Pharmaceuticals Inc 2834
SUWN Over the counter Sunwin Stevia International In 2834
SVRA Nasdaq Savara Inc 2834
SXTC Nasdaq China SXT Pharmaceuticals Inc 2834
SYN American Synthetic Biologics Inc 2834
SYRS Nasdaq Syros Pharmaceuticals Inc 2834
TARO New York Taro Pharmaceutical Industries 2834
TBPH Nasdaq Theravance Biopharma Inc 2834
TEVA New York Teva Pharmaceutical Industries 2834
TGTX Nasdaq TG Therapeutics Inc 2834
TLGT Nasdaq Teligent Inc 2834
TLRY Nasdaq Tilray Inc 2834
TNTY Over the counter True Nature Holding Inc 2834
TNXP Nasdaq Tonix Pharmaceuticals Holding 2834
TORC Nasdaq resTORbio, Inc. 2834
TRVI Nasdaq Trevi Therapeutics Inc 2834
TXMD Nasdaq TherapeuticsMD Inc 2834
UMRX Nasdaq Unum Therapeutics Inc 2834
VERU Nasdaq Veru Inc 2834
VNDA Nasdaq Vanda Pharmaceuticals Inc. 2834
VRCA Nasdaq Verrica Pharmaceuticals Inc 2834
VRTX Nasdaq Vertex Pharmaceuticals Incorpo 2834
VTVT Nasdaq vTv Therapeutics Inc 2834
VVUS Nasdaq VIVUS, Inc. 2834
XENE Nasdaq Xenon Pharmaceuticals Inc 2834
XNCR Nasdaq Xencor Inc 2834
XOMA Nasdaq XOMA Corp 2834
ZFGN Nasdaq Zafgen Inc 2834
ZGNX Nasdaq Zogenix, Inc. 2834
ZTS New York Zoetis Inc 2834
Results 200 through 232 of 232